when is tirzepatide off patent Generic Zepbound: Landscape & Options As the patent for semaglutide,

Dosing Titration in Retatrutide Trials

Any changes in liver-related symptoms or new abnormalities in home monitoring (such as unexplained weight gain suggesting fluid retention) should prompt earlier review

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent one of the most transformative pharmacologic developments in metabolic medicine

The STEP trials purposely excluded individuals with a history of major depressive disorder (MDD), bipolar disorder, schizophrenia, or other significant mental illnesses as well as participants with past suicide attempts or who had experienced clinically significant suicidal thoughts